LidoSite FDA Approval History
Last updated by Judith Stewart, BPharm on Jan 28, 2021.
FDA Approved: Yes (First approved May 10, 2004)
Brand name: LidoSite
Generic name: lidocaine and Epinephrine
Dosage form: Topical System
Company: Vyteris, Inc.
Treatment for: Local Anesthesia
LidoSite (lidocaine and epinephrine) is an iontophoretic delivery system providing local analgesia prior to the administration of superficial dermatological procedures.
Development timeline for LidoSite
|May 10, 2004||Approval LidoSite Vyteris, Inc. - Treatment for Localized Pain|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.